Armata Pharmaceuticals (ARMP) Convertible Debt (2023 - 2026)

Armata Pharmaceuticals (ARMP) posted Convertible Debt of $254.9 million for Q1 2026, up 65.68% sequentially from $153.9 million in Q4 2025.

Armata Pharmaceuticals (ARMP) Convertible Debt (2023 - 2026) Analysis & Trends

Armata Pharmaceuticals has reported Convertible Debt for 4 years, with the latest figure at $254.9 million in Q1 2026.

Quarterly Convertible Debt changed N/A year-over-year to $254.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $254.9 million (changed N/A YoY) and the FY2025 annual result came in at $153.9 million, up 367.7% from the prior year.
Convertible Debt climbed to $254.9 million in Q1 2026 per ARMP's latest filing, from $153.9 million in the prior quarter.
Over five years, Convertible Debt peaked at $254.9 million in Q1 2026 and troughed at $30.0 million in Q3 2024.
A 4-year average of $80.0 million and a median of $41.3 million in 2023 frame the typical range for Convertible Debt.
The sharpest annual moves came in 2024 and 2025: Convertible Debt tumbled 43.89% in 2024, then surged 367.7% in 2025.
Over 4 years, Convertible Debt stood at $58.6 million in 2023, then plunged by 43.89% to $32.9 million in 2024, then soared by 367.7% to $153.9 million in 2025, then surged by 65.68% to $254.9 million in 2026.
According to Business Quant data, Convertible Debt over the past three periods registered $254.9 million, $153.9 million, and $30.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.35 Bn	131.50 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.12 Bn	78.12 Bn	3.93 Bn
3	Argenx Se	65.22 Bn	60.03 Bn	1.37 Bn
4	Moderna	58.98 Bn	53.84 Bn	52.00 Mn
5	BeOne Medicines	42.08 Bn	36.99 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn
7	BioNTech SE	27.98 Bn	9.59 Bn	668.28 Mn
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn
9	Royalty Pharma	27.30 Bn	26.47 Bn	-
10	Armata Pharmaceuticals	178.59 Mn	154.59 Mn	-

Download Data